Click for best price
Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, Share 2024
The global Gastric Inhibitory Polypeptide Monoclonal Antibody market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Recombinant Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Gastric Inhibitory Polypeptide Monoclonal Antibody include MyBiosource, Inc., LifeSpan BioSciences, Inc, Assay Genie, Arigo Biolaboratories Corp., RayBiotech, Inc., Biorbyt, Creative Biolabs, GeneTex and OriGene Technologies, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Gastric Inhibitory Polypeptide Monoclonal Antibody is an unconjugated antibody to Gastric Inhibitory Polypeptide.
This report aims to provide a comprehensive presentation of the global market for Gastric Inhibitory Polypeptide Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Inhibitory Polypeptide Monoclonal Antibody. This report contains market size and forecasts of Gastric Inhibitory Polypeptide Monoclonal Antibody in global, including the following market information:
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Gastric Inhibitory Polypeptide Monoclonal Antibody companies in 2023 (%)
We surveyed the Gastric Inhibitory Polypeptide Monoclonal Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Segment Percentages, by Type, 2023 (%)
Recombinant
Non-recombinant
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Segment Percentages, by Application, 2023 (%)
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Inhibitory Polypeptide Monoclonal Antibody revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Gastric Inhibitory Polypeptide Monoclonal Antibody revenues share in global market, 2023 (%)
Key companies Gastric Inhibitory Polypeptide Monoclonal Antibody sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Gastric Inhibitory Polypeptide Monoclonal Antibody sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
MyBiosource, Inc.
LifeSpan BioSciences, Inc
Assay Genie
Arigo Biolaboratories Corp.
RayBiotech, Inc.
Biorbyt
Creative Biolabs
GeneTex
OriGene Technologies, Inc.
??Abcam
Cell Signaling Technology, Inc.
Abbexa
Bio-Techne
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastric Inhibitory Polypeptide Monoclonal Antibody, market overview.
Chapter 2: Global Gastric Inhibitory Polypeptide Monoclonal Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of Gastric Inhibitory Polypeptide Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastric Inhibitory Polypeptide Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastric Inhibitory Polypeptide Monoclonal Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Gastric Inhibitory Polypeptide Monoclonal Antibody Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gastric Inhibitory Polypeptide Monoclonal Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Overall Market Size
2.1 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size: 2023 VS 2030
2.2 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales: 2019-2030
3 Company Landscape
3.1 Top Gastric Inhibitory Polypeptide Monoclonal Antibody Players in Global Market
3.2 Top Global Gastric Inhibitory Polypeptide Monoclonal Antibody Companies Ranked by Revenue
3.3 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue by Companies
3.4 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales by Companies
3.5 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Gastric Inhibitory Polypeptide Monoclonal Antibody Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Gastric Inhibitory Polypeptide Monoclonal Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Inhibitory Polypeptide Monoclonal Antibody Players in Global Market
3.8.1 List of Global Tier 1 Gastric Inhibitory Polypeptide Monoclonal Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Inhibitory Polypeptide Monoclonal Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size Markets, 2023 & 2030
4.1.2 Recombinant
4.1.3 Non-recombinant
4.2 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue & Forecasts
4.2.1 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2024
4.2.2 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2025-2030
4.2.3 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
4.3 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales & Forecasts
4.3.1 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2024
4.3.2 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2025-2030
4.3.3 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
4.4 By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2023 & 2030
5.1.2 Flow Cytometry
5.1.3 ELISA
5.1.4 Western Blot
5.1.5 Immunoprecipitation
5.1.6 Immunofluorescence
5.1.7 Other
5.2 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue & Forecasts
5.2.1 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2024
5.2.2 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2025-2030
5.2.3 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
5.3 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales & Forecasts
5.3.1 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2024
5.3.2 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2025-2030
5.3.3 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
5.4 By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2023 & 2030
6.2 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue & Forecasts
6.2.1 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2024
6.2.2 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2025-2030
6.2.3 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
6.3 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales & Forecasts
6.3.1 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2024
6.3.2 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2025-2030
6.3.3 By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2030
6.4.2 By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2030
6.4.3 US Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.4.4 Canada Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.4.5 Mexico Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2030
6.5.2 By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2030
6.5.3 Germany Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5.4 France Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5.5 U.K. Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5.6 Italy Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5.7 Russia Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5.8 Nordic Countries Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.5.9 Benelux Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2030
6.6.2 By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2030
6.6.3 China Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.6.4 Japan Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.6.5 South Korea Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.6.6 Southeast Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.6.7 India Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2030
6.7.2 By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2030
6.7.3 Brazil Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.7.4 Argentina Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, 2019-2030
6.8.3 Turkey Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.8.4 Israel Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.8.5 Saudi Arabia Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
6.8.6 UAE Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 MyBiosource, Inc.
7.1.1 MyBiosource, Inc. Company Summary
7.1.2 MyBiosource, Inc. Business Overview
7.1.3 MyBiosource, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.1.4 MyBiosource, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.1.5 MyBiosource, Inc. Key News & Latest Developments
7.2 LifeSpan BioSciences, Inc
7.2.1 LifeSpan BioSciences, Inc Company Summary
7.2.2 LifeSpan BioSciences, Inc Business Overview
7.2.3 LifeSpan BioSciences, Inc Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.2.4 LifeSpan BioSciences, Inc Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.2.5 LifeSpan BioSciences, Inc Key News & Latest Developments
7.3 Assay Genie
7.3.1 Assay Genie Company Summary
7.3.2 Assay Genie Business Overview
7.3.3 Assay Genie Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.3.4 Assay Genie Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.3.5 Assay Genie Key News & Latest Developments
7.4 Arigo Biolaboratories Corp.
7.4.1 Arigo Biolaboratories Corp. Company Summary
7.4.2 Arigo Biolaboratories Corp. Business Overview
7.4.3 Arigo Biolaboratories Corp. Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.4.4 Arigo Biolaboratories Corp. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.4.5 Arigo Biolaboratories Corp. Key News & Latest Developments
7.5 RayBiotech, Inc.
7.5.1 RayBiotech, Inc. Company Summary
7.5.2 RayBiotech, Inc. Business Overview
7.5.3 RayBiotech, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.5.4 RayBiotech, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.5.5 RayBiotech, Inc. Key News & Latest Developments
7.6 Biorbyt
7.6.1 Biorbyt Company Summary
7.6.2 Biorbyt Business Overview
7.6.3 Biorbyt Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.6.4 Biorbyt Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.6.5 Biorbyt Key News & Latest Developments
7.7 Creative Biolabs
7.7.1 Creative Biolabs Company Summary
7.7.2 Creative Biolabs Business Overview
7.7.3 Creative Biolabs Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.7.4 Creative Biolabs Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.7.5 Creative Biolabs Key News & Latest Developments
7.8 GeneTex
7.8.1 GeneTex Company Summary
7.8.2 GeneTex Business Overview
7.8.3 GeneTex Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.8.4 GeneTex Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.8.5 GeneTex Key News & Latest Developments
7.9 OriGene Technologies, Inc.
7.9.1 OriGene Technologies, Inc. Company Summary
7.9.2 OriGene Technologies, Inc. Business Overview
7.9.3 OriGene Technologies, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.9.4 OriGene Technologies, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.9.5 OriGene Technologies, Inc. Key News & Latest Developments
7.10 ??Abcam
7.10.1 ??Abcam Company Summary
7.10.2 ??Abcam Business Overview
7.10.3 ??Abcam Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.10.4 ??Abcam Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.10.5 ??Abcam Key News & Latest Developments
7.11 Cell Signaling Technology, Inc.
7.11.1 Cell Signaling Technology, Inc. Company Summary
7.11.2 Cell Signaling Technology, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Business Overview
7.11.3 Cell Signaling Technology, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.11.4 Cell Signaling Technology, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.11.5 Cell Signaling Technology, Inc. Key News & Latest Developments
7.12 Abbexa
7.12.1 Abbexa Company Summary
7.12.2 Abbexa Gastric Inhibitory Polypeptide Monoclonal Antibody Business Overview
7.12.3 Abbexa Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.12.4 Abbexa Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.12.5 Abbexa Key News & Latest Developments
7.13 Bio-Techne
7.13.1 Bio-Techne Company Summary
7.13.2 Bio-Techne Gastric Inhibitory Polypeptide Monoclonal Antibody Business Overview
7.13.3 Bio-Techne Gastric Inhibitory Polypeptide Monoclonal Antibody Major Product Offerings
7.13.4 Bio-Techne Gastric Inhibitory Polypeptide Monoclonal Antibody Sales and Revenue in Global (2019-2024)
7.13.5 Bio-Techne Key News & Latest Developments
8 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Production Capacity, Analysis
8.1 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Production Capacity, 2019-2030
8.2 Gastric Inhibitory Polypeptide Monoclonal Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Inhibitory Polypeptide Monoclonal Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Inhibitory Polypeptide Monoclonal Antibody Supply Chain Analysis
10.1 Gastric Inhibitory Polypeptide Monoclonal Antibody Industry Value Chain
10.2 Gastric Inhibitory Polypeptide Monoclonal Antibody Upstream Market
10.3 Gastric Inhibitory Polypeptide Monoclonal Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Inhibitory Polypeptide Monoclonal Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Gastric Inhibitory Polypeptide Monoclonal Antibody in Global Market
Table 2. Top Gastric Inhibitory Polypeptide Monoclonal Antibody Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Share by Companies, 2019-2024
Table 5. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales by Companies, (K Units), 2019-2024
Table 6. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Gastric Inhibitory Polypeptide Monoclonal Antibody Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Gastric Inhibitory Polypeptide Monoclonal Antibody Product Type
Table 9. List of Global Tier 1 Gastric Inhibitory Polypeptide Monoclonal Antibody Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastric Inhibitory Polypeptide Monoclonal Antibody Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), 2019-2024
Table 15. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), 2025-2030
Table 16. By Application ? Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), 2019-2024
Table 20. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), 2025-2030
Table 21. By Region ? Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), 2019-2024
Table 25. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), 2025-2030
Table 26. By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2019-2024
Table 29. By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2025-2030
Table 30. By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2019-2024
Table 33. By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2025-2030
Table 34. By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2019-2024
Table 37. By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2025-2030
Table 38. By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2019-2024
Table 41. By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Sales, (K Units), 2025-2030
Table 46. MyBiosource, Inc. Company Summary
Table 47. MyBiosource, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 48. MyBiosource, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. MyBiosource, Inc. Key News & Latest Developments
Table 50. LifeSpan BioSciences, Inc Company Summary
Table 51. LifeSpan BioSciences, Inc Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 52. LifeSpan BioSciences, Inc Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. LifeSpan BioSciences, Inc Key News & Latest Developments
Table 54. Assay Genie Company Summary
Table 55. Assay Genie Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 56. Assay Genie Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Assay Genie Key News & Latest Developments
Table 58. Arigo Biolaboratories Corp. Company Summary
Table 59. Arigo Biolaboratories Corp. Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 60. Arigo Biolaboratories Corp. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Arigo Biolaboratories Corp. Key News & Latest Developments
Table 62. RayBiotech, Inc. Company Summary
Table 63. RayBiotech, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 64. RayBiotech, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. RayBiotech, Inc. Key News & Latest Developments
Table 66. Biorbyt Company Summary
Table 67. Biorbyt Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 68. Biorbyt Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Biorbyt Key News & Latest Developments
Table 70. Creative Biolabs Company Summary
Table 71. Creative Biolabs Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 72. Creative Biolabs Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Creative Biolabs Key News & Latest Developments
Table 74. GeneTex Company Summary
Table 75. GeneTex Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 76. GeneTex Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. GeneTex Key News & Latest Developments
Table 78. OriGene Technologies, Inc. Company Summary
Table 79. OriGene Technologies, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 80. OriGene Technologies, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. OriGene Technologies, Inc. Key News & Latest Developments
Table 82. ??Abcam Company Summary
Table 83. ??Abcam Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 84. ??Abcam Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. ??Abcam Key News & Latest Developments
Table 86. Cell Signaling Technology, Inc. Company Summary
Table 87. Cell Signaling Technology, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 88. Cell Signaling Technology, Inc. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Cell Signaling Technology, Inc. Key News & Latest Developments
Table 90. Abbexa Company Summary
Table 91. Abbexa Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 92. Abbexa Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Abbexa Key News & Latest Developments
Table 94. Bio-Techne Company Summary
Table 95. Bio-Techne Gastric Inhibitory Polypeptide Monoclonal Antibody Product Offerings
Table 96. Bio-Techne Gastric Inhibitory Polypeptide Monoclonal Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Bio-Techne Key News & Latest Developments
Table 98. Gastric Inhibitory Polypeptide Monoclonal Antibody Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Production by Region, 2019-2024 (K Units)
Table 101. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Production by Region, 2025-2030 (K Units)
Table 102. Gastric Inhibitory Polypeptide Monoclonal Antibody Market Opportunities & Trends in Global Market
Table 103. Gastric Inhibitory Polypeptide Monoclonal Antibody Market Drivers in Global Market
Table 104. Gastric Inhibitory Polypeptide Monoclonal Antibody Market Restraints in Global Market
Table 105. Gastric Inhibitory Polypeptide Monoclonal Antibody Raw Materials
Table 106. Gastric Inhibitory Polypeptide Monoclonal Antibody Raw Materials Suppliers in Global Market
Table 107. Typical Gastric Inhibitory Polypeptide Monoclonal Antibody Downstream
Table 108. Gastric Inhibitory Polypeptide Monoclonal Antibody Downstream Clients in Global Market
Table 109. Gastric Inhibitory Polypeptide Monoclonal Antibody Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastric Inhibitory Polypeptide Monoclonal Antibody Segment by Type in 2023
Figure 2. Gastric Inhibitory Polypeptide Monoclonal Antibody Segment by Application in 2023
Figure 3. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, 2019-2030 (US$, Mn)
Figure 7. Gastric Inhibitory Polypeptide Monoclonal Antibody Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue in 2023
Figure 9. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 11. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 12. By Type - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 15. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 16. By Application - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 20. By Region - Global Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 21. By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 22. By Country - North America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 23. US Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 28. Germany Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 29. France Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 37. China Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 41. India Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 43. By Country - South America Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 44. Brazil Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Gastric Inhibitory Polypeptide Monoclonal Antibody Sales Market Share, 2019-2030
Figure 48. Turkey Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Gastric Inhibitory Polypeptide Monoclonal Antibody Revenue, (US$, Mn), 2019-2030
Figure 52. Global Gastric Inhibitory Polypeptide Monoclonal Antibody Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Gastric Inhibitory Polypeptide Monoclonal Antibody by Region, 2023 VS 2030
Figure 54. Gastric Inhibitory Polypeptide Monoclonal Antibody Industry Value Chain
Figure 55. Marketing Channels
